TAVR as Anti-Inflammatory? An effect few imagined

We never saw it coming, such a pleiotropic effect: who would have though a mechanical device could have such a systemic anti-inflammatory effect? Transcatheter aortic valve replacement (TAVR) does in fact have it. 

TAVI como antiinflamatorio

The shear stress aortic stenosis produces activates multiple inflammatory responses mediated by monocytes. This study identified the most important mechanoreceptor, involved in the inflammatory cascade called Piezo-1. This receptor is a potentially druggable target, and although we have not yet been able to block it, we can prevent it from increasing inflammation by lowering shear stress with TAVR. 

The chance of aortic stenosis accelerating or provoking inflammation per se was unknown until now. 

TAVR has given us the unique opportunity to compare the activation status of monocytes under high shear stress (before TAVR) and under low shear stress (after TAVR).

The activation status of monocytes was determined using MAN-1 antibodies, which are specific for the activated B2 integrin Mac-1.


Read also: Computerized Tomography as First Coronary Study?


Activated monocytes adhere to stimulated endothelial cells, phagocytic activity, oxidized low density lipoproteins and cytokine expression. 

Different assays were carried out to collect this information before and after TAVR.

After TAVR, shear stress was reduced, with the resulting reduction of Mac-1 activity, cell adhesion, low density lipoprotein oxidation and inflammatory marker expression in the circulating monocytes. 


Read also: Considerations for Optimal Device Selection in TAVR.


Researchers also observed in the lab, under strictly controlled conditions, that shear stress-dependent calcium influx and monocyte adhesion are mediated by the mechanosensitive ion channel Piezo-1. 

Expression of this receptor depends on shear stress and it clearly drops after TAVR.

Conclusion

This study shows that shear stress produced by diseases such as severe aortic stenosis activates multiple monocyte functions mediated by the mechanosensitive Piezo-1. It also shows the anti-inflammatory effect of TAVR and therefore its new and unknow therapeutic benefit. 

CIRCULATIONA-A-120-045536

Original Title: Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress–Induced, Piezo-1–Mediated Monocyte Activation.

Reference: Sara Baratchi et al. Circulation. 2020;142:1092–1105.  DOI: 10.1161/CIRCULATIONAHA.120.045536.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....